Global Cell Freezing Media Market Insights Forecasts to 2033

• The Global Cell Freezing Media Market Size was Valued at USD 154.1 Million in 2023
• The Market Size is Growing at a CAGR of 9.66% from 2023 to 2033
• The Worldwide Cell Freezing Media Market Size is Expected to Reach USD 387.5 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

The Cell Freezing Media Market Size is Anticipated to Exceed USD 387.5 Million by 2033, Growing at a CAGR of 9.66% from 2023 to 2033.

 

Market Overview                                 

Cell freezing, also known as cryopreservation, is an approach that preserves cells, tissues, organelles, and other biological constructions by cooling them to extremely low temperatures. This mechanism aids in the genetic stabilization of biological materials while also minimizing ice-crystal formation, which can rupture the cell membrane and cause cell death. Stem cells and other viable tissues, which have a high potential for use in basic research and many medical applications, cannot be stored for an extended period using simple cooling or freezing because ice crystal formation, osmotic shock, and membrane damage during freezing and thawing cause cell death. The cell freezing media market continues to expand over the forecast period as R&D activities increase. Manufacturers increased focus on developing novel cell preservation technologies, government initiatives for pharmaceutical research, and decreased fertility rates. Furthermore, Innovations in cell freezing media formulation and cryopreservation techniques, along with the leveraging of cell freezing media applications in domains that include tissue engineering, cellular treatment, and stem cell research, have boosted the market significantly. Additionally, supporting government laws for regenerative medicine and cell-based research is expected to improve the market worldwide.

 

Report Coverage

This research report categorizes the market for the cell freezing media market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the cell freezing media market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the cell freezing media market.

 

Driving Factors

The increasing acceptance of cell culture in cancer treatment, drug discovery, and vaccine development has contributed to additional funds for cell-based research. Several businesses are investing in cell culture technology, indicating a potential industry growth. The rising use of harvesting in cell culture to cure a range of illnesses is expected to fuel market expansion.

 

Restraining Factors

Cell storage involves expensive equipment, immense storage space, and a high storage cost, that could hamper the market in several low- and middle-income countries. In addition, the delayed recovery rate and limited applicability to tropical species might constitute a barrier to market growth.

 

Market Segmentation

The cell freezing media market share is classified into product, application, and end-use.

 

• The DMSO segment accounted for the largest revenue share over the forecast period.

Based on the product, the cell freezing media market is categorized into DMSO, glycerol, and others. Among these, the DMSO segment accounted for the largest revenue share over the forecast period. DMSO is a key ingredient in cryobiology due to its aprotic and solvation characteristics. It prevents ice crystal formation both intracellularly and extracellularly at sub-zero temperatures during slow freezing, and because of these antifreeze qualities, DMSO is now widely utilized as a cryoprotectant.

 

• The stem cell lines segment holds the highest market share through the forecast period.

Based on the application, the cell freezing media market is categorized into stem cell lines, cancer cell lines, and others. Among these, the stem cell lines segment holds the highest market share through the forecast period. In line with this, stem cells differ in their ability to differentiate into specific cell types, making them invaluable in a variety of applications including tissue engineering, regenerative medicine, and drug development. Using cell freezing media for the continuous processing of such medical products will result in the easiest market penetration over the time frame of the projection.

 

• The pharmaceutical and biotechnological companies segment is anticipated to grow at the highest CAGR during the forecast period.

The cell freezing media market is categorized by end-use into pharmaceutical and biotechnological companies, research & academic institutes, and others. Among these, the pharmaceutical and biotechnological companies segment is anticipated to grow at the highest CAGR during the forecast period. Pharmaceutical and biotechnological companies are the primary end users of cell freezing media for biologics development, toxicological testing, and drug discovery. Cell freezing media are essential to preserving cell lines, primary cells, and modified cells for use in high-throughput screening testing, target validation studies, and biomanufacturing.

 

Regional Segment Analysis of the Cell Freezing Media Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the cell freezing media market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

 

North America is projected to hold the largest share of the cell freezing media market over the forecast period. The market is driven by modern healthcare infrastructure, developed economies, significant players, and established supply channels. Furthermore, the incidence of diseases and the expanding elderly population have fueled the race to produce improved and efficacious remedies through the biopharmaceutical industry. This has increased demand for cell freezing media and is projected to continue generating revenue over the coming years.

 

Asia Pacific is expected to grow at the fastest CAGR growth in the cell freezing media market during the forecast period. Asia Pacific is an area with a supportive government, a focus on low labor and operating costs, and a major hub for biologics manufacturing, particularly monoclonal antibodies. The development of MAbs frequently requires heavy use of mammalian cell cultures that are continuously treated and require cryopreservation.

 

 Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the cell freezing media market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Sartorius AG
• BioLife Solutions, Inc.
• AMSBIO
• BIOGENUIX MEDSYSTEMS PVT.LTD
• Bio-Techne
• Hemacare Corporation
• HiMedia Laboratories
• Capricorn Scientific
• Mediatech, Inc.
• Cell Applications, Inc.
• Nippon Genetics
• PromoCell GmbH
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In April 2024, Thermo Fisher Scientific introduced new ENERGY STAR Certified TSX Universal Series ULT freezers with enhanced temperature management and faster recovery periods.

 

• In April 2024, Merck introduced the first all-in-one genetic stability assay to speed up biosafety testing.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the cell freezing media market based on the below-mentioned segments: 

 

Global Cell Freezing Media Market, By Product

• DMSO
• Glycerol
• Others

 

Global Cell Freezing Media Market, By Application

• Stem Cell Lines
• Cancer Cell Lines
• Others

 

Global Cell Freezing Media Market, By End-use

• Pharmaceutical and Biotechnological Companies
• Research & Academic Institutes
• Others

 

Global Rugged Electronics Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa